Abstract
Introduction
In the general economy of a myocardial infarction, the loss of cardiac tissue triggers a regulated signalling cascade leading to replacement with scar tissue [1, 2] 
. The inflammatory state associated with the early phases of wound healing is characterized by a high regenerative and proliferative capacity of both cardiac and mobilized stem cells. These initial adaptive mechanisms, especially sustained by neurohormonal activation, further lead to a deleterious counterpart represented by fibroblasts proliferation and extracellular matrix (ECM) deposition, with the aim to compensate tissue loss and prevent ventricular dilation. At this point, the proliferative capacity and the actual viability of myocardiocytes are dramatically reduced, with the generation of a non-functional scar.
This event not only compromises elastic and mechanical properties of the ventricle leading to pump failure, but also is at the root of alterations of the anatomical conduction system, originating potential re-entrant circuits and increasing the risk of ventricular tachyarrhythmias, which represent the main cause for sudden death in heart failure patients [2] [3] [4] . In this scenario, stem cell therapy by transfer of bone marrow (BM)-derived stem and precursor cells into the infarcted myocardium has been shown to improve left ventricular systolic function [5] . Similar results were obtained by the application of granulocyte colony-stimulating factor (G-CSF), alone or in combination with stem cell factor, which is known to mobilize BM-derived cells [6] [7] [8] [9] [10] . Interestingly, the beneficial effects of these therapies are claimed to be due to a significant degree of structural regeneration of the infarcted hearts by transdifferentiation of the immigrated BM-derived cells to cardiomyocytes [11] [12] [13] [14] [15] . However, a true in situ cardiac transdifferentiation has not been demonstrated yet, an actual cell viability and engrafting following cell administration have been found to be low, weakening the concept of a real tissue replacement or regeneration [16] . Additionally, new insights on cell-based myocardial repair have been recently reported, shifting emphasis on the importance of paracrine factors secreted by BM-derived cells [17] [18] [19] [20] [21] [22] [23] [9] [32, 33] and, more importantly, electromechanical coupling with the host cardiomyocytes [33] [34] [35] .
. These findings, together with contradictory results related to the actual transdifferentiation of different cell types used in cardiac therapy [24, 25], raised concerns about an effective, total, functional engraftment of the injected cells. Despite the mechanisms underlying their beneficial effect on cardiac performance, this non-functional integration of injected or endogenously mobilized cells might constitute an arrythmogenic load within the cardiac environment, increasing the risk for pro-arrhythmia. To this extent, recent reports have shown that the transfer of skeletal myoblasts [26] into decompensated hearts failed to electromechanically integrate and provoked ventricular tachycardias in patients [27]. Moreover, certain types of cardiomyocytes derived from in vitro differentiated embryonic stem cells exhibited prolonged action potential durations after depolarizations, and a potential for arrhythmogenesis [28]. The achievement of both a cardiomyocyte differentiation and a precise integration of the injected cells into the myocardial wall, in order to augment synchronized contractility and avoid potentially life-threatening alterations in the electrical conduction of the heart, still remains a major target to be pursued. Recently, G-CSF fuelled the interest of researchers, not only for its well-known ability to mobilize the endogenous BM-derived stem cells reserve, but also for its direct effect on cardiomyocytes. Harada et al.
Another major concern in myoblast transplantation, besides the caveat of arrhythmic events, it is the loss of a significant fraction of injected myoblasts upon engraftment. A long-term follow-up study of patients suffering from heart failure and treated with myoblast transplantation has shown a consistent reduction in the percentage of cells in the grafted segments exhibiting systolic thickening recovery [36] . In this model, efficiency of myoblast transplantation was hampered by a high rate of cell death, which was incompletely compensated by proliferation within the scar [36] . Considering the enhancing effect of G-CSF on angiogenesis [37] , macrophage-induced production of matrix metalloproteases (MMPs) that leads to ECM remodelling [38, 39] , and proliferation of L6a1 rat myoblasts before differentiation to myotubes [40] , Aharinejad and colleagues genetically engineered myoblasts to overexpress G-CSF prior to transfer to the failing heart following myocardial infarction [41] . This 
Materials and methods

Scaffold preparation
Cell proliferation
Cell proliferation was estimated by total cellular DNA content measurement. Cellular DNA content was obtained as previously described [50] . 
Western blotting
Cells on scaffolds were lysed by addition of 0.5 ml of lysis buffer per gram of scaffold as previously described [52] . 
Transmission electron microscopy (TEM)
Samples were routinely prepared as previously described [54] . (Fig. 1A, B (Fig. 2) . (Fig. 4A, B) .
Cell morphology and differentiation
Cell viability and proliferation, as studied by analysis by live/dead assay, total DNA content per construct and percentage of Ki67ϩ cells (Fig. 4C-E) , demonstrated a statistical significant increase for the cells cultured on PLLA/GCSF scaffolds and for the 2D cell cultures exposed to PLLA/GCSF (P Ͻ 0.001).
Immunofluorescence analysis revealed Cx43 expression, along with a higher fibrillar distribution of cytoplasmic actin in the PLLA/GCSF scaffolds, with respect to the PLLA/Ctrl control (Fig. 5A-F (Fig. 6A) . Immunofluorescence also showed appearance of cardiac-specific isoform of troponin I in the PLLA/GCSF group. (Fig. 7B) . These results were confirmed with Western blotting analysis that showed (Fig. 8A, B) . Elongated eccentric mitochondria, typical of muscular cells, could be detected on releasing scaffold (Fig. 8C) . Along with these findings, several types of cellular junctions could be observed (Fig. 8D-F [57, 58] .
Interestingly, antigen was localized in cytoplasm and presented a granular pattern of expression, clearly indicating a non-mature organization of the protein inside the cell
co-expression of Cx43 and cTnI in the PLLA/GCSF patches, confirming a cardiac pre-commitment of myoblasts seeded in these scaffolds and a direct effect of G-CSF released from the polymer on cells in conventional culture (Fig. 6B). A non-cardiac specific dystrophin antibody recognizing a 60 kD fragment of the native protein was used as a general marker for myoblasts. The contemporary presence of both myoblast and cardiac-specific markers could reliably suggest different stages in the differentiation process. However, morphological and immunophenotypic changes achieved by myoblasts in this setting were not compatible with a complete differentiation in cardiomyocyte and cells did not acquire beating capability which is related to the appearance of a functional cardiac-specific calcium handling system.
Transmission electron microscopy
TEM analysis revealed engrafted myoblasts closely adhering on PLLA fibres. Cells on PLLA/GCSF polymer appeared elongated with more evidently represented rough endoplasmic reticulum (RER) and Golgi apparatus with respect to the control scaffold, reliably indicating a higher metabolic activity
Fig. 4 (A) PLLA/Ctrl seeded with C2C12 after 48 hrs culturing (100ϫ); (B) PLLA/GCSF seeded with C2C12 after 48 hrs culturing (100ϫ); (C) cells viability analysis in PLLA/GCSF and in PLLA/Ctrl scaffolds after 48 hrs of culture; (D) cell proliferation evaluated by measuring the total DNA content per construct; (E) percentage of Ki67 expression in both types of scaffolds. An increase in cell viability and proliferation could be detected in the PLLA/GCSF scaffold in comparison to
To date, several types of polymers have been proposed to obtain cardiac grafts and PLLA polymers represent the most attractive avenues for this purpose because of their advantageous mechanical properties, plasticity and biocompatibility [59] . Many [60] , with the possibility of being combined to the newest methodologies of cell seeding [61, 62] . The electrospinning process allows for control over the morphology of the fibres and use of a wide variety of polymers. The small diameter fibres produced by electrospinning have the advantage of a large surface-to-volume ratio, as well as a high permeability and interconnecting pore structure, both of which are desirable in a biological setting.
Fig. 5 Confocal microscopy. Immunofluorescence staining for Cx43, F-actin and nuclei. (A, B) PLLA/Ctrl seeded with C2C12 after 48 hrs (400ϫ). (C-F) PLLA/GCSF seeded with C2C12 after 48 hrs (400ϫ). Cx43 expression and a higher fibrillar distribution of cytoplasmic actin in the PLLA/GCSF scaffolds, with respect to the PLLA/Ctrl control could be seen (A-F). Cx43 antibody nicely stained membranes of cells (C, D, F) engrafted among polymeric fibres, but could also be detected in the perinuclear zone (E). different techniques have been developed for the construction of cardiovascular scaffolds with this polymer. Electrospinning is one of the most effective and functional approaches
Also, polymers combined with grow factors, cytokines and drugs have been developed [48, 63] , generating drug releasing systems capable of focused and localized delivery of molecules according to the local environment requirements. A broad range of applications for electrospun fibres has been suggested [64, 65] , ranging from drug delivery [66] [67] [68] [69] [70] to gene therapy [71] . [72] . Moreover, we produced some preliminary data on scaffold tailored for cardiovascular structures [73] . These data represent a proof of principle of the possibility to produce a scaffold suitable for stem cells seeding, containing the appropriate factors to induce a guided differentiation towards the desired phenotype. In these settings differentiation would be realized within a 3D ECM-like environment closely mimicking the tissue native architecture and allowing a harmonious ongoing cell growth and differentiation for tissue regeneration.
Recent studies indicate that there is a lack of functional electromechanical coupling between the majority of grafted myoblasts and cardiomyocytes [34, 35] . G-CSF has been shown to induce the expression of Cx43 [29] , a cardiac-specific gap junction protein crucial for effective electromechanical association [30, 31] . The idea to produce a biodegradable device able to induce differentiation of myoblasts -one of the most commonly used cell types in cardiac therapy -in order to ameliorate their engrafting and effectiveness, guided us to explore the potential role of a G-CSF functionalized PLLA scaffold for myocardial tissue engineering. To our knowledge, the association of electrospun poly(lactide) polymer and G-CSF for cardiovascular differentiation purposes is novel.
For drug loading, a direct incorporation of the growth factor during the scaffold preparation has been performed as previously described [74] . In contrast with adsorption or microencapsulation, this approach overcomes the drawbacks of these methods [75] [16] .
Conclusion
The 
